Helomics
1 known investors
Predictive Oncology (POAI) operates an AI/ML platform, CORE (Computational Research Engine), powered by a biobank of over 150,000 tumor samples across 137 cancer types to predict tumor-drug response and support oncology drug discovery and repurposing. The platform is aimed at pharmaceutical and drug-development teams seeking to select drug/tumor combinations and introduce tumor heterogeneity data at pre-clinical stages.